The patient was neurologically intact at presentation, except for a mild ataxic gait and dysmetria of the right arm. Interestingly, he underwent a baseline CT scan of the brain ( Fig. 2) as part of a meningitis work-up as an 11-month-old infant. The scan appeared to demonstrate normal findings. Even retrospective review of the imaging study showed no indication of the cerebellar mass lesions.
There was no family history of cancers at a young age.
Operation. The patient was placed in the prone position. His head was held in a military-tuck position in a 3-pin Mayfield head holder. Free-run facial nerve, soft-palate, and tongue electromyographic monitoring was performed together with upper-and lower-extremity somatosensory evoked potential monitoring for intraoperatively. A midline skin incision and occipital/suboccipital craniotomy were made to approach both lesions. A corticectomy in the left cerebellar hemisphere, based on intraoperative ultrasound, was used to resect the firm, well-circumscribed hemispheric tumor en bloc.
Next we turned our attention to the midline lesion. A small corticectomy through the inferior vermis was made to reach the soft but vascular tumor. This lesion was grossly different from the first tumor. A gross-total re- (Fig. 3 ). The biphasic tumor had predominantly solid compact areas with bipolar cells having round to oval nuclei. There were interspersed cystic areas with myxoid material containing round, process-poor cells. Many Rosenthal fibers and calcifications were noted in the compact areas. Focally round cells with perinuclear halos resembling oligodendrocytes were seen. Immunostaining with GFAP showed diffuse positivity of the tumor cells, and immunostaining with Ki 67 showed a low proliferation index of 1-2%. Chromosome analysis of a 5-day primary culture revealed a normal male karyotype with no evidence of clonal abnormality.
The paramedian cerebellar tumor exhibited a highly cellular small blue cell neoplasm (Fig. 4) . The tumor cells were densely packed with a focal nodular pattern. They had hyperchromatic and pleomorphic, elongated nuclei and scant cytoplasm. There were focal pale nodules with formation of neuropil, highlighted by lack of reticulin staining. Synaptophysin was present in the pale nodules and was concordant with the neuronal differentiation that is represented in the pale nodules. Numerous mitotic figures and apoptotic bodies were seen. The GFAP immunostain demonstrated residual infiltrated neuropil and reactive astrocytes. Immunostain with Ki 67 showed a high proliferation index of 95%. A P53 immunostain showed diffuse and strong nuclear positivity in over 90% of the tumor cells. Chromosome analysis of a 7-day primary culture revealed a near-tetraploid clone with multiple structural and numerical changes in 8 of 20 cells examined: (83,XXYY, +X, add (1)(p13) x2, +9, -10, -10,?der (12;?) x2, -13, -13, -16, -16, -17, -17, -18, -18,der (18;22)(q10;q10)x2,-21,-21,+3mar [8] ). A diagnosis of medulloblastoma with focal anaplasia and residual nodular pattern (WHO Grade IV [2007] ) was rendered.
Postoperative Course. The postoperative course was unremarkable. The patient remained neurologically intact except for mild cerebellar signs and symptoms. Postoperative MR imaging of the brain showed no residual tumor ( Fig. 5) . At 6 months, the patient is completing treatment for medulloblastoma based on a collaborative multiinstitutional study. This treatment consists of craniospinal radiation therapy to a dose of 23.4 Gy followed by a boost to the tumor bed to a total of 55.8 Gy. He is currently undergoing chemotherapy consisting of 4 cycles of high-dose drugs followed after each course by stem cell rescue. In this protocol we do not upstage risk categorization based on degree of anaplasia. Clinical staging determines the risk categorization.
Treatment Rationale. There is no evidence to date that children with medulloblastoma with focal anaplasia require a different or a more intensive treatment approach. It is widely accepted that children with large cell/anaplastic medulloblastoma have a poorer prognosis and therefore require a more aggressive treatment approach. The current Children's Oncology Group trial for those with medulloblastoma who are considered to be at high risk for recurrence includes children with any degree of anaplasia, and they all receive higher doses of craniospinal radiation to 36 Gy. Future prospective studies may shed light on the correlation between the degree of anaplasia and outcome.
We did not specifically treat the child in this report for the JPA because this lesion was completely resected. In addition the area where the JPA was present received at least a dose of 23.4 Gy.
Discussion
Multiple synchronous brain tumors are most commonly encountered in the form of metastatic disease. The incidence of primary multiple brain tumors is much lower. These lesions are usually of the same histological type: multifocal gliomas 4 and multiple meningiomas, schwannomas, ependymomas, teratomas, 34 and hemangioblastomas. 30 Synchronous germinoma 15 and, less commonly, synchronous multicentric pleomorphic xanthoastrocytoma 21 and JPA associated with neurofibromatosis Type 1 24 have been reported in the pediatric age group. Multiple primary brain tumors of different cell types are very rare and have been documented only in single case reports and small case series. 1, 5, 6, 8, 9, [11] [12] [13] [14] 17, 19, 22, 25, 28, 29, [31] [32] [33] [35] [36] [37] Reported combinations of multiple primary brain tumors are summarized in Table 1 . The most common combination found in the largest series of 18 adult patients was astrocytoma and meningioma. 8 The second tumor may be diagnosed or suspected pre-or intraoperatively. It may be detected months or years after the successful treatment of a single intracranial tumor. 11 In a few patients, the second tumor was discovered at postmortem examination. 8 In some cases, more than 2 primary brain tumors have been found in the same patient. 11 In our review of the literature, we found only 1 case of a pediatric patient with 2 primary brain tumors: a 4-year-old boy without a genetic predisposition to CNS tumors presented with a fourth ventricular choroid plexus papilloma and a frontal subependymal giant cell astrocytoma. 18 To the best of our knowledge, we have reported the first pediatric case in which a medulloblastoma and a JPA presented as synchronous primary brain tumors.
Several theories have been developed to explain the origin of multiple primary brain tumors of different histological types. It has been postulated that a given carcinogenic stimulus could produce a neoplastic transformation of contiguous cells into different histological cell types or could cause a transformation only in susceptible locations, leading to primary brain tumors with different histological characteristics or locations. 2, 23 According to the Cohnheim theory, embryonic residua, from which brain tumors of all histological types arise, could become neoplastic at various times, causing different types of primary brain tumors at different times. 12 The theory did not explain why these cells remained latent for years, nor why only an occasional rest of embryonic cells developed into cancer. 3 A systemic carcinogenic principle, such as Li-Fraumeni syndrome, 16 neurocutaneous syndromes, 8, 24 and related syndromes linked to germline mutations of genes that normally help to control cell growth, is hypothesized to greatly increase a susceptibility to cancer. This has the potential of producing multiple intracranial neoplasms as well as tumors involving other organ systems. 12 Mutations may be inherited or may arise de novo early in embryogenesis or in one of the parent's germ cells.
Other authors 6, 11, 20 have speculated that one of the tumors may act as an irritant, capable of stimulating the development of the other adjacent tumor. In our case, given the adjacent locations of the tumors, this theory seems plausible and more than mere coincidence.
Exposure to radiation can play an important role in the development of multiple primary brain tumors. The observation has been made that patients who receive cranial irradiation for a single brain neoplasm are at higher risk for the development of a second tumor at a later date. 10, 27 Trauma has also been implicated as one of the causal factors of tumorigenesis. 11 Our patient has no history of radiotherapy or head trauma. On the other hand, the advent of neuroimaging is thought to be responsible for factitiously increasing the incidence of multiple brain tumors by the increased presence of a surveillance artifact.
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Conclusions
As our case illustrates, two separate intracranial masses may not represent CNS dissemination of a single primary tumor. A symptomatic tumor is an indication for surgery. An asymptomatic second tumor may be followed clinically and radiographically if not reached easily through the same craniotomy at the time of first surgery, or it may be resected for definitive diagnosis, as described in this report.
The potential role of genetic factors, head injury, radiotherapy, and "irritative effect" of other adjacent tumors in the development of multiple primary brain tumors remains speculative. Tumorigenesis is likely a complex multistep process that can be influenced by tumor environment, activation of oncogenes, or the loss of tumor suppressor genes.
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